In naturally aged mouse models (1820 months old), daily oral administration of 5-amino-1mq capsules for 12 consecutive weeks significantly reduced NNMT activity and increased NAD+ levels in various tissues (liver, kidney, adipose tissue), along with markedly elevated expression of SIRT1 and SIRT3 proteins
BPC-157 supplements are not approved treatments for gastrointestinal disorders, underscoring the importance of ongoing research in the field of gut health
TB-500: Ac-L-K-K-T-E-T-Q Research Overview This blend combines BPC-157 , a gastric pentadecapeptide, with TB-500 , the active fragment of Thymosin 4
Other mild effects while adapting to treatment are headaches, nausea, or fatigue
Retrieved February 16, 2022